Forte Biosciences Q2 EPS $(0.42) Down From $(0.21) YoY
Author: Benzinga Newsdesk | August 14, 2023 04:33pm
Forte Biosciences (NASDAQ:FBRX) reported quarterly losses of $(0.42) per share. This is a 100 percent decrease over losses of $(0.21) per share from the same period last year.